Copay Assistance – Good For Patients, Bad For Prices
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Similar Posts
Has Mammography Created an Epidemic of Pseudo-Survivorship?
ByadminKaren Vogt’s breast cancer journey began like many others, with her breasts painfully squeezed into a mammography machine. At age 52, it was far from her first mammogram, but this scan would be the most consequential by far. It revealed microcalcifications, little areas of breast tissue speckled with deposits of calcium that her radiologist worried…
Guess Who Is Struggling to Pay Their Medical Bills!
ByadminHere is a picture from the Kaiser Family Foundation showing which Americans were most likely to report problems paying medical bills last year. The sad news is that just about any way you divide it, a hell of a lot of Americans are having a heckuva time paying these bills:
Why It’s Not Time for Health Care Rationing
Byadmin“Why It’s Not Time for Health Care Rationing” – Hastings Center Report
Rural Voters Elected President Trump. Is He about to Ruin Their Local Hospitals?
ByadminIt’s not an easy time to be a small, rural hospital. Insurance companies aren’t willing to pay generously for your services, given your measly market share. You are increasingly forced to compete against large integrated healthcare systems – conglomerations of urban, suburban and rural providers armed with big marketing budgets and specialized (generously reimbursed!) services….
Why Trumpcare Is DOA: It Doesn't Address Outrageous Healthcare Prices
ByadminPaul Ryan is “excited” that the American Health Care Act, as Republicans call their bill, will trim the federal budget by several hundred billion dollars over the next decade. The 24 million people who are expected to lose insurance under the AHCA aren’t excited about the bill, which will cut government spending at their expense,…
A Drug to Treat Cancer and Heart Disease (Miracle Cure or Media Hype?)
ByadminIn a recent New York Times article, physician-author Siddhartha Mukherjee wrote about a clinical trial that he characterized as “beautiful,” for potentially illuminating a surprising connection between heart disease and cancer. Mukherjee is a justifiably acclaimed writer, who publishes regularly in The New Yorkerand The New York Times, and who won a Pulitzer for his bestselling book The Emperor of All Maladies. But…